Financial AgreementsLexicon's exclusive licensing agreement with Viatris provides positive external validation from a large biopharma for sotagliflozin's future market opportunity across its multiple indications.
Market OpportunitiesSota presents significant market opportunities, offering multiple revenue streams and growth potential.
Partnership And Strategic AlliancesLexicon and Viatris join forces for important regional sota rollout, broadening sota’s global commercialization potential, particularly with a partner experienced in launching various therapeutics.